Cargando…

Drugs for COVID-19 Treatment: A New Challenge

COVID-19 infection is a new disease and our knowledge is limited; day in and day out more and more interesting yet diverse observations are reported by the different research groups from different corners of the world. So, there is an urgent requirement of the invention of some effective and efficie...

Descripción completa

Detalles Bibliográficos
Autores principales: Talukder, Pratik, Saha, Arunima, Roy, Sohini, Ghosh, Gargi, Roy, Debshikha Dutta, Barua, Snejuti
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10037400/
https://www.ncbi.nlm.nih.gov/pubmed/36961509
http://dx.doi.org/10.1007/s12010-023-04439-4
_version_ 1784911871014338560
author Talukder, Pratik
Saha, Arunima
Roy, Sohini
Ghosh, Gargi
Roy, Debshikha Dutta
Barua, Snejuti
author_facet Talukder, Pratik
Saha, Arunima
Roy, Sohini
Ghosh, Gargi
Roy, Debshikha Dutta
Barua, Snejuti
author_sort Talukder, Pratik
collection PubMed
description COVID-19 infection is a new disease and our knowledge is limited; day in and day out more and more interesting yet diverse observations are reported by the different research groups from different corners of the world. So, there is an urgent requirement of the invention of some effective and efficient drugs that can carry out the end of the deadly viral infection. Throughout the world, there have been many efforts carried out in different labs to invent such a drug and also identifying any pre-existing drugs which can carry out the killing of the virus. In this review, an effort has been made to understand the potential drugs which can be used against the SARS-CoV-2 viral infection. Again, the strategies on the current and the future drug discovery mechanisms against the SARS-CoV-2 are also mentioned. The different drugs made and the drugs re-used and also the drugs which are in the making process in different research laboratories across the world are also mentioned. To combat this unexpected crisis, we still need some more efforts from the different scientific communities around the world for finding a cure against this viral infection and this is needed to be done for the prevention of more loss of human life.
format Online
Article
Text
id pubmed-10037400
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Springer US
record_format MEDLINE/PubMed
spelling pubmed-100374002023-03-24 Drugs for COVID-19 Treatment: A New Challenge Talukder, Pratik Saha, Arunima Roy, Sohini Ghosh, Gargi Roy, Debshikha Dutta Barua, Snejuti Appl Biochem Biotechnol Review Article COVID-19 infection is a new disease and our knowledge is limited; day in and day out more and more interesting yet diverse observations are reported by the different research groups from different corners of the world. So, there is an urgent requirement of the invention of some effective and efficient drugs that can carry out the end of the deadly viral infection. Throughout the world, there have been many efforts carried out in different labs to invent such a drug and also identifying any pre-existing drugs which can carry out the killing of the virus. In this review, an effort has been made to understand the potential drugs which can be used against the SARS-CoV-2 viral infection. Again, the strategies on the current and the future drug discovery mechanisms against the SARS-CoV-2 are also mentioned. The different drugs made and the drugs re-used and also the drugs which are in the making process in different research laboratories across the world are also mentioned. To combat this unexpected crisis, we still need some more efforts from the different scientific communities around the world for finding a cure against this viral infection and this is needed to be done for the prevention of more loss of human life. Springer US 2023-03-24 2023 /pmc/articles/PMC10037400/ /pubmed/36961509 http://dx.doi.org/10.1007/s12010-023-04439-4 Text en © The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature 2023, Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law. This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic.
spellingShingle Review Article
Talukder, Pratik
Saha, Arunima
Roy, Sohini
Ghosh, Gargi
Roy, Debshikha Dutta
Barua, Snejuti
Drugs for COVID-19 Treatment: A New Challenge
title Drugs for COVID-19 Treatment: A New Challenge
title_full Drugs for COVID-19 Treatment: A New Challenge
title_fullStr Drugs for COVID-19 Treatment: A New Challenge
title_full_unstemmed Drugs for COVID-19 Treatment: A New Challenge
title_short Drugs for COVID-19 Treatment: A New Challenge
title_sort drugs for covid-19 treatment: a new challenge
topic Review Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10037400/
https://www.ncbi.nlm.nih.gov/pubmed/36961509
http://dx.doi.org/10.1007/s12010-023-04439-4
work_keys_str_mv AT talukderpratik drugsforcovid19treatmentanewchallenge
AT sahaarunima drugsforcovid19treatmentanewchallenge
AT roysohini drugsforcovid19treatmentanewchallenge
AT ghoshgargi drugsforcovid19treatmentanewchallenge
AT roydebshikhadutta drugsforcovid19treatmentanewchallenge
AT baruasnejuti drugsforcovid19treatmentanewchallenge